Clinical Trial Update: "Pharmacokinetic Study of Fondaparinux in Inpatients With Renal Dysfunction" [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study assessing how fondaparinux behaves in inpatients with renal dysfunction to inform dosing in this population; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Insufficiency

Drugs mentioned

• Fondaparinux (fondaparinux)

Snippet

Sponsor: Duke University | Conditions: Renal Insufficiency | Phase 1 | Status: COMPLETED